Antibiotic resistance is racing toward a global crisis, with “superbugs” projected to cause over 10 million deaths annually ...

Investors have bought into the promise of CRISPR technology for years. The ability to target and edit genes to treat cancer ...

But CRISPR is a long-term story that is still in the early innings. The company has moved past its proof-of-concept phase, ...

The past few years have been challenging for the biotech.

China research team at Wuhan University of Science and Technology uses CRISPR to remove HIV DNA from human cells, marking a potential breakthrough in treatment.

CRISPR Therapeutics' CASGEVY gene-editing therapy targets severe SCD and TDT. Click here to read why CRSP stock is rated as a Buy.

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

Researchers developed a CRISPR-based system that spreads through bacterial populations to disable antibiotic resistance genes ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

Scientists in China report removing HIV from human DNA using gene-editing technology. Experts say the findings are promising but still far from a confirmed cure.